Zackary Irani Biography and Net Worth

CEO of Biomerica

Mr. Zackary Irani has been a Director of the Company, and has been serving as the Company’s Chairman of the Board and Chief Executive Officer since April 29, 1997. Prior to that time, Mr. Irani served as the Company’s Vice-President of Business Development. He has been an employee of the Company since 1986. During fiscal 2008 and 2009, Mr. Irani also served as Chairman of the Board of Lancer Orthodontics, Inc. and served as Lancer’s Chief Executive Officer from April 1997 until April 2004.

What is Zackary S. Irani's net worth?: The estimated net worth of Zackary S. Irani is at least $453.61 thousand as of August 26th, 2026. Mr. Irani owns 242,570 shares of Biomerica stock worth more than $453,606 as of October 8th. This net worth evaluation does not reflect any other investments that Mr. Irani may own. Learn More about Zackary S. Irani's net worth.
How do I contact Zackary S. Irani?: The corporate mailing address for Mr. Irani and other Biomerica executives is 17571 Von Karman Avenue, Irvine CA, 92614. Biomerica can also be reached via phone at (949) 379-2875 and via email at [email protected]. Learn More on Zackary S. Irani's contact information.
Has Zackary S. Irani been buying or selling shares of Biomerica?: Zackary S. Irani has not been actively trading shares of Biomerica in the last ninety days. Most recently, on Wednesday, August 26th, Zackary S. Irani bought 31,250 shares of Biomerica stock. The stock was acquired at an average cost of $1.60 per share, with a total value of $50,000.00. Following the completion of the transaction, the chief executive officer now directly owns 242,570 shares of the company's stock, valued at $388,112. Learn More on Zackary S. Irani's trading history.
Who are Biomerica's active insiders?: Biomerica's insider roster includes Allen Barbieri (Vice Chairman), Zackary Irani (CEO), and David Moatazedi (Director). Learn More on Biomerica's active insiders.
Are insiders buying or selling shares of Biomerica?: During the last twelve months, Biomerica insiders bought shares 4 times. They purchased a total of 92,500 shares worth more than $148,000.00. The most recent insider tranaction occured on August, 26th when Director David Moatazedi bought 10,000 shares worth more than $16,000.00. Insiders at Biomerica own 18.0% of the company. Learn More about insider trades at Biomerica.
Information on this page was last updated on 8/26/2026.

Zackary S. Irani Insider Trading History at Biomerica

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/26/2026	Buy	31,250	$1.60	$50,000.00	242,570
5/24/2023	Buy	62	$12.88	$798.56	127,545
5/12/2023	Buy	212	$9.36	$1,984.32	127,482
5/9/2023	Buy	37	$11.12	$411.44	127,207
4/28/2023	Buy	225	$10.72	$2,412.00	127,170
4/26/2023	Buy	875	$10.08	$8,820.00	126,620
1/24/2023	Buy	250	$22.48	$5,620.00	125,520
2/9/2018	Buy	62	$30.64	$1,899.68	107,567
2/2/2018	Buy	125	$31.68	$3,960.00	107,504
1/25/2018	Buy	254	$32.24	$8,188.96	107,125
1/23/2018	Buy	62	$30.80	$1,909.60	107,125
11/14/2016	Buy	50	$15.52	$776.00	97,650
11/8/2016	Buy	62	$13.92	$863.04	97,625
11/4/2016	Buy	125	$15.60	$1,950.00	97,575
9/7/2016	Buy	24	$21.20	$508.80	97,450
8/12/2016	Buy	395	$23.84	$9,416.80	97,054
8/11/2016	Buy	462	$23.04	$10,644.48	96,629
8/10/2016	Buy	125	$21.76	$2,720.00	96,491
8/3/2016	Buy	326	$16.80	$5,476.80	96,240
8/1/2016	Buy	675	$15.04	$10,152.00	95,740
11/13/2015	Buy	625	$6.64	$4,150.00	88,940
6/8/2015	Buy	375	$8.64	$3,240.00
5/22/2015	Buy	250	$6.80	$1,700.00
5/11/2015	Buy	2,250	$7.28	$16,380.00
9/6/2012	Buy	875	$5.60	$4,900.00

Zackary S. Irani Buying and Selling Activity at Biomerica

Biomerica Company Overview

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Today's Range

Now: $1.87

$1.86

$1.91

50 Day Range

MA: $2.01

$1.49

$2.78

2 Week Range

Now: $1.87

$1.45

$3.21

Volume

6,221 shs

Average Volume

36,841 shs

Market Capitalization

$5.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.38